Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Ascentage Pharma Group (OTC : ASPHF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company's geographical segments include the United States and Mainland China.
Quote
| Last: | $4.53 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $4.53 |
| Close: | $4.53 |
| High: | $4.53 |
| Low: | $4.53 |
| Volume: | 100 |
| Last Trade Date Time: | 06/05/2026 10:25:33 am |
Stock Data
| Market Cap: | $2,460,998,269 |
|---|---|
| Float: | 290,212,060 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | CN |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Ascentage Pharma Group (OTC: ASPHF).
